World TB Day Event Emphasizes Border Issues in the Americas
“When HIV and TB Collide” The TB Alliance recently participated in a Global Health Council event in Miami, Florida, called
Tuberculosis: Agreement reached on development of nitroimidazole-related compound for TB treatment
2002 MAR 8 – Chiron Corporation (CHIR) and the Global Alliance for TB Drug Development have agreed to license terms
Tuberculosis Never Went Away
A FEW YEARS AGO a passenger on a flight from Paris to New York infected 13 others with multi-drug-resistant tuberculosis.
Nonprofits Seek to Develop Drugs
The Global Alliance for TB Drug Development has no medical labs, which might seem a odd for a group that
TB Breakthrough?
Chiron Corp. signed an innovative deal last week that could set a pattern for how corporations and nonprofits can work
Chiron: Parsing the TB universe
The Global Alliance for TB Drug Development is holding up its new deal with Chiron Corp. as one example of
Global Alliance for TB Drug Development Obtains Exclusive Worldwide License of Anti-TB Drug, PA-824
The US-based Global Alliance for TB Drug Development, a one-year old private and public venture participation company has announced that
A Hard Sale: Chiron and Non-Profit Group Agree on Drug-Development Deal
In one of the first drug development deals between a drug maker and a nonprofit organization, the Global Alliance for
Nonprofit Alliance Will Pay Chiron For Rights to a Potential TB Drug
EMERYVILLE, Calif. — In one of the first drug-development deals between a drug maker and a nonprofit organization, the Global